IFP Advisors, Inc - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 202 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$12,000
+33.3%
532
+50.7%
0.00%
Q1 2021$9,000
+50.0%
353
+54.8%
0.00%
Q4 2020$6,000
-25.0%
228
-0.4%
0.00%
Q3 2020$8,000
+700.0%
229
+1808.3%
0.00%
Q2 2020$1,0000.0%120.0%0.00%
Q1 2020$1,0000.0%120.0%0.00%
Q4 2019$1,0000.0%120.0%0.00%
Q3 2019$1,000
-98.4%
12
-97.8%
0.00%
-100.0%
Q1 2019$62,000
-57.8%
552
-64.6%
0.01%
-11.1%
Q4 2018$147,000
-60.5%
1,561
-47.0%
0.01%
-40.0%
Q3 2018$372,000
+17.0%
2,943
-22.4%
0.02%
+15.4%
Q2 2018$318,000
+439.0%
3,794
+274.9%
0.01%
+333.3%
Q1 2018$59,0000.0%1,0120.0%0.00%0.0%
Q4 2017$59,000
-59.0%
1,012
-59.2%
0.00%
-50.0%
Q3 2017$144,000
-8.3%
2,482
+90.9%
0.01%
-14.3%
Q2 2017$157,000
+145.3%
1,300
+128.1%
0.01%
+133.3%
Q1 2017$64,000
+3.2%
5700.0%0.00%0.0%
Q4 2016$62,000
-34.0%
5700.0%0.00%
-40.0%
Q3 2016$94,000
+16.0%
5700.0%0.01%0.0%
Q2 2016$81,000
+30.6%
570
+3.3%
0.01%
-37.5%
Q1 2016$62,000
-52.3%
552
-36.6%
0.01%
-11.1%
Q4 2015$130,0008710.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders